Catalyst Wire Dossier Catalyst Wire Dossier

RN1001

Avotermin · Renovo
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RN1001, covering 2009-02-19 to 2009-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects [Phase 1, Phase 2]

See pricing